Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Investigating Development of Autoimmunity in Post-Acute COVID-19 Syndrome (PACS)

  • Read more about Investigating Development of Autoimmunity in Post-Acute COVID-19 Syndrome (PACS)

MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance

  • Read more about MG Granules Improve COVID-19 Efficacy and Safety of Convalescent Exercise Tolerance

Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine

  • Read more about Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine

The Canadian Respiratory Research Network Long COVID-19 Study

  • Read more about The Canadian Respiratory Research Network Long COVID-19 Study

COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics

  • Read more about COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics

TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19

  • Read more about TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

  • Read more about Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above

Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

  • Read more about Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

  • Read more about Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection

  • Read more about Antihistamines, Amantadine and Evolution of the SARS-CoV-2 Infection

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 130
  • Page 131
  • Page 132
  • Page 133
  • Current page 134
  • Page 135
  • Page 136
  • Page 137
  • Page 138
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA